Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"?
D003256:Community Participation; D003365:Costs and Cost Analysis; D004341:Drug Evaluation / Q000379:methods*; D009934:Organization and Administration; D006113:United Kingdom